


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.67%
-0.05%
-2.18%
-3.53%
BLTE
Belite Bio Inc
$149.18
Strengths

Upgraded on attractively valued
BLTE Price Performance
$177.58 (-15.99%)
$159.96 (-6.74%)
$112.4 (+32.72%)
$56.6 (+163.57%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
BLTE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BLTE Street Sentiment is extremely bullish and have negative views on the near-term outlook
BLTE has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Jan 28, 2026
Reiterate
Buy
H.C. Wainwright
Jan 26, 2026
Initiate
Buy
B of A Securities
Jan 07, 2026
Initiate
Overweight
Morgan Stanley
Dec 03, 2025
Upgrade
Outperform
Mizuho
Dec 02, 2025
Reiterate
Buy
HC Wainwright & Co.
JNJ
Johnson & Johnson
239.24
-0.31%
ANNX
Annexon
5.25
-2.14%
AZN
Astrazeneca
183.40
-1.96%
What is BLTE current stock price?
What are BLTE stock strengths?
What is BLTE Risk Level?
What is BLTE market cap and volume?
What is BLTE current Stock IQ?
Should I buy BLTE stock right now?
Is BLTE a Strong Buy right now?
What does a 'Strong Buy' rating mean for BLTE?
What does a 'Strong Sell' rating mean for BLTE?
What factors influence BLTE's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
BLTE
Belite Bio Inc
Current Price
$149.18
Runners Also Watch
JNJ
Johnson & Johnson
239.24
-0.31%
ANNX
Annexon
5.25
-2.14%
AZN
Astrazeneca
183.40
-1.96%

BLTE Price Performance
$177.58 (-15.99%)
$159.96 (-6.74%)
$112.4 (+32.72%)
$56.6 (+163.57%)
BLTE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
BLTE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BLTE Street Sentiment is extremely bullish and have negative views on the near-term outlook
BLTE has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
BLTE Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued
BLTE Trading Signals
BLTE is trading 25.53% below analyst target price of $187.27, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BLTE Stock trends
BLTE Stock performance
BLTE Stock analysis
BLTE investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.